Listed

Lineage Cell Therapeutics, Inc.

LCTXNYSECIK 876343HealthcareFiscal year ends Dec 31

Reports and events: 623 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Lineage Cell Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0916:15 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-040058
2023-11-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-040057
2023-09-0717:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-031993
2023-08-1016:16 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-027552
2023-08-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-027545
2023-07-2716:05 ETDEF 14AProxy statementPeriod 2023-07-270001493152-23-025680
2023-06-2117:00 ET8-K8.01 Other events0001493152-23-022030
2023-05-1817:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-018160
2023-05-1116:15 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-016392
2023-05-1116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-016388
2023-04-2716:15 ET10-K/AAnnual report, amendedPeriod 2022-12-310001493152-23-013813
2023-03-0916:16 ET10-KAnnual reportPeriod 2022-12-310001493152-23-007129
2023-03-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-007127
2023-01-2308:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-002127
2022-11-1016:16 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-031359
2022-11-1016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-031351
2022-10-3108:05 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-029913
2022-10-2817:20 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001493152-22-029887
2022-09-3017:00 ET8-K/A5.02 Departure or appointment of officers or directors0001493152-22-027295
2022-09-2617:29 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-026840
2022-08-1116:16 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-022085
2022-08-1116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-022077
2022-07-0716:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-018802
2022-06-1716:15 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-22-017162
2022-05-1216:16 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013041
2022-05-1216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-013033
2022-05-1219:54 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-012893
2022-04-2916:06 ETDEF 14AProxy statementPeriod 2022-04-290001493152-22-011552
2022-03-2517:23 ETSC 13D/AOwnership report, active investor, amended0000919574-22-002416
2022-03-1016:37 ET10-KAnnual reportPeriod 2021-12-310001493152-22-006520
2022-03-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-006506
2022-02-1409:00 ET8-K8.01 Other events0001493152-22-004309
2021-12-2106:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-032109
2021-12-2006:06 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-031964
2021-12-1316:10 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-031281
2021-11-1016:16 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-027859
2021-11-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-027855
2021-09-3017:29 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-024236
2021-09-1507:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-21-022765
2021-08-1216:21 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-019518
2021-08-1216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-019506
2021-08-0317:00 ETDEF 14AProxy statementPeriod 2021-08-030001493152-21-018445
2021-07-2117:00 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-21-017458
2021-06-1607:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-014503
2021-06-0107:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-013294
2021-05-1316:21 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-011299
2021-05-1316:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-011290
2021-05-0517:00 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-010533
2021-05-0317:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-010348
2021-04-2217:00 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-009474

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.